Mitral Valve Repair & Replacement

Who is it for?

According to the data from clinical trials, MitraClip and Pascal are promising for treating severe mitral valve regurgitation in patients with severe symptoms but are not good candidates for open-heart surgery to repair or replace their valve. Both can give these patients a shot at feeling better and living longer.



Data from a clinical research study called the Endovascular Valve Edge-to-Edge Repair Study II (EVEREST II) High Risk Registry (HRR), found that after one year, patients who underwent the experimental procedure had a survival rate of 75% versus a survival rate of 55% for patients who received medication only. Additionally, after a year, 74% of survivors had no or only slight limitations on physical activity.

Improving Patient Care

The Society for Cardiovascular Angiography & Interventions (SCAI) is the leading nonprofit medical society representing invasive and interventional cardiology. Founded in 1978, SCAI’s mission is to lead the global interventional cardiovascular community through education, advocacy, research, and quality patient care. 

SCAI has dedicated its work to advancing the profession and is the designated society for guidance, representation, professional recognition, education, and research opportunities for invasive and interventional cardiology professionals. For more than 40 years, SCAI has personified professional excellence and innovation globally, fostering a trusted community of more than 4,500 members dedicated to medical advancement and lifesaving care for adults and children with cardiovascular disease.  

Society for Cardiovascular Angiography & Interventions®

1100 17th Street NW, Suite 400, Washington, DC 20036